Nitroso-redox imbalance affects cardiac structure and function
- PMID: 23449427
- PMCID: PMC4052892
- DOI: 10.1016/j.jacc.2012.12.016
Nitroso-redox imbalance affects cardiac structure and function
Figures

Comment on
-
High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease.J Am Coll Cardiol. 2013 Mar 5;61(9):926-32. doi: 10.1016/j.jacc.2012.09.066. J Am Coll Cardiol. 2013. PMID: 23449426 Clinical Trial.
References
-
- Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med. 2004;351:2112–4. - PubMed
-
- Hare JM, Mangal B, Brown J, et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol. 2008;51:2301–9. - PubMed
-
- Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation. 2003;107:1951–3. - PubMed
-
- George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114:2508–16. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources